Health Care & Life Sciences » Biotechnology | OncoMed Pharmaceuticals Inc.

OncoMed Pharmaceuticals Inc. | Ownership

Companies that own OncoMed Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
PRIMECAP Management Co.
5,563,700
14.45%
-3,200
0.01%
06/30/2018
BVF Partners LP
4,099,589
10.65%
-153,600
0.64%
06/30/2018
Perceptive Advisors LLC
2,620,897
6.81%
0
0.14%
06/30/2018
The Vanguard Group, Inc.
995,608
2.59%
112
0%
06/30/2018
Renaissance Technologies LLC
757,400
1.97%
59,300
0%
06/30/2018
Alyeska Investment Group LP
534,309
1.39%
17,086
0.01%
06/30/2018
New York Life Investment Management LLC
380,000
0.99%
60,000
0.01%
06/30/2018
Candriam Belgium SA
380,000
0.99%
0
0%
07/31/2018
D. E. Shaw & Co. LP
326,269
0.85%
19,506
0%
06/30/2018
Peter B. Cannell & Co., Inc.
303,071
0.79%
-900
0.03%
06/30/2018

About OncoMed Pharmaceuticals

View Profile
Address
800 Chesapeake Drive
Redwood City California 94063
United States
Employees -
Website http://www.oncomed.com
Updated 09/14/2018
OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.